Daily Market Reports | Mar 11 2026
This story features AMPLITUDE ENERGY LIMITED, and other companies.
For more info SHARE ANALYSIS: AEL
The company is included in ASX300 and ALL-ORDS
An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities.
In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed stocks, also enlarging the number of stocks that make up the FNArena universe.
One key difference is the *Extra* Edition will not be updated daily, but merely “regularly” depending on availability of suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.
Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication may not be up to date, or yet awaiting another update by FNArena’s team of journalists.
Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.
The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.
The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.
COMPANIES DISCUSSED IN THIS ISSUE
Click on a symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)
AEL BET BMN CNB CSL CSX CYG EDV ELD FLC GHM GNP MSB MYE ORA ORE PDN SLS SNZ TCL TLC WEB WRK
AEL AMPLITUDE ENERGY LIMITED
Crude Oil – Overnight Price: $2.67
Canaccord Genuity rates ((AEL)) as Buy (1) –
Amplitude Energy’s Isabella well has intersected 8.2m of net gas pay without encountering a gas-water contact. Wireline logging operations will be conducted in coming days.
Canaccord Genuity believes hitting gas at Isabella in the Waare C should help rebuild confidence in the use of seismic direct hydrocarbon indicators. Target rises to $3.65 from $3.35 and a Buy rating is maintained.
This report was published on March 2, 2026.
Target price is $3.65 Current Price is $2.67 Difference: $0.98
If AEL meets the Canaccord Genuity target it will return approximately 37% (excluding dividends, fees and charges).
Current consensus price target is $3.23, suggesting upside of 21.5%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of 20.60 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 12.96.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 21.0, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 12.7.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of 22.30 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 11.97.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 26.9, implying annual growth of 28.1%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 9.9.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
BET BETMAKERS TECHNOLOGY GROUP LIMITED
Gaming – Overnight Price: $0.17
Canaccord Genuity rates ((BET)) as Upgrade to Buy from Speculative Buy (1) –
Betmakers Technology delivered a first half result where revenue was ahead of Canaccord Genuity’s estimates. The $6m in EBITDA was also a welcome surprise.
Commentary posits strong momentum exists going forward with a number of new customer wins going live in the second quarter and another eight scheduled for the second half.
The broker expects operating leverage will continue to emerge in the upcoming quarterly results.
Rating is upgraded to Buy from Speculative Buy. Target rises to 24c from 22c.
This report was published on March 2, 2026.
Target price is $0.24 Current Price is $0.17 Difference: $0.065
If BET meets the Canaccord Genuity target it will return approximately 37% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of 0.00 cents.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
BMN BANNERMAN ENERGY LIMITED
Uranium – Overnight Price: $4.05
Canaccord Genuity rates ((BMN)) as Speculative Buy (1) –
Canaccord Genuity observes the CNNC transaction is significant for Bannerman Energy and Etango, introducing a highly credentialled partner, which slashes funding risk and provides offtake certainty.
FEED studies for Etango were completed mid 2024 and the development is expected to be sanctioned shortly once the transaction reaches completion.
Bannerman Energy will retain a 55% interest in the joint venture with a 52.25% interest in Etango. The brroker retains a Speculative Buy rating and reduces the target to $5.80 from $5.99.
This report was published on March 3, 2026.
Target price is $5.80 Current Price is $4.05 Difference: $1.75
If BMN meets the Canaccord Genuity target it will return approximately 43% (excluding dividends, fees and charges).
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
CNB CARNABY RESOURCES LIMITED
Mining – Overnight Price: $0.41
Moelis rates ((CNB)) as Buy (1) –
Moelis assesses the first half results were largely “irrelevant” as the company is in pre-production with the primary takeaway being the balance sheet showing $14.6m in cash that is ample for funding up to full feasibility and FID.
The broker estimates the business will require a further $50m to get to first production, which should not be an impediment given the current market cap and copper price. Buy rating and $1.05 target.
This report was published on March 6, 2026.
Target price is $1.05 Current Price is $0.41 Difference: $0.635
If CNB meets the Moelis target it will return approximately 153% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Moelis forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 3.30 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 12.58.
Forecast for FY27:
Moelis forecasts a full year FY27 dividend of 0.00 cents and EPS of 5.40 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 7.69.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
CSL CSL LIMITED
Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $144.56
Canaccord Genuity rates ((CSL)) as Buy (1) –
If CSL can achieve FY26 guidance where Andembry features more than cost reductions then Canaccord Genuity considers this will be a win and one which the company’s narrative can be “re-consolidated”.
The product is the best internally developed example from the company’s R&D since Idelvion, the broker contends, and CSL badly needs a winner. Buy rating. Target is $180.
This report was published on March 2, 2026.
Target price is $180.00 Current Price is $144.56 Difference: $35.44
If CSL meets the Canaccord Genuity target it will return approximately 25% (excluding dividends, fees and charges).
Current consensus price target is $205.76, suggesting upside of 43.8%(ex-dividends)
Forecast for FY26:
Current consensus EPS estimate is 886.7, implying annual growth of N/A.
Current consensus DPS estimate is 438.4, implying a prospective dividend yield of 3.1%.
Current consensus EPS estimate suggests the PER is 16.1.
Forecast for FY27:
Current consensus EPS estimate is 1044.8, implying annual growth of 17.8%.
Current consensus DPS estimate is 495.4, implying a prospective dividend yield of 3.5%.
Current consensus EPS estimate suggests the PER is 13.7.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.6
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
CSX CLEANSPACE HOLDINGS LIMITED
Medical Equipment & Devices – Overnight Price: $0.53
Research as a Service (RaaS) rates ((CSX)) as No Rating (-1) –
CleanSpace posted revenue growth of 10% in the first half amid US tariff uncertainty, the government shutdown and a mine closure in Indonesia.
Research as a Service (RaaS) notes gross margins held at industry highs and costs were well contained. Guidance implies around 19% revenue growth in the second half with positive operating EBITDA and cash flow for the full year.
The analyst makes several adjustments to valuation including an increase in the risk-free rate, offset by removal of NSW Health debt and period rolling forward.
Valuation is unchanged at $1.05. Research as a Service (RaaS) research doesn’t carry any targets, ratings or recommendations. Investors can draw conclusions from valuations and commentary.
This report was published on March 3, 2026.
Target price is $1.05 Current Price is $0.53 Difference: $0.525
If CSX meets the Research as a Service (RaaS) target it will return approximately 100% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Research as a Service (RaaS) forecasts a full year FY26 dividend of 0.00 cents and EPS of 0.80 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 65.63.
Forecast for FY27:
Research as a Service (RaaS) forecasts a full year FY27 dividend of 0.00 cents and EPS of 2.90 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 18.10.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
CYG COVENTRY GROUP LIMITED
Hardware & Equipment – Overnight Price: $0.44
Taylor Collison rates ((CYG)) as Hold (3) –
Coventry Group delivered first half results that were “optically” very weak, Taylor Collison asserts.
Several non-recurring factors affected the results including the unwinding of -$5m in accounts payable and ERP costs of -$800,000 as well as restructuring costs of -$600,000. Additional expenditure of -$2m followed the relocation of a store in Mackay.
The broker weighs the potential breakup of the company’s divisions, maintaining when separated they are more valuable than the current share price implies.
If the company can rectify the cash drain, the breakup thesis can be achieved and the broker has a Hold rating, with improving operating performance required to review its stance. No target is provided.
This report was published on March 5, 2026.
Current Price is $0.44. Target price not assessed.
The company’s fiscal year ends in June.
Forecast for FY26:
Taylor Collison forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 8.70 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 5.06.
Forecast for FY27:
Taylor Collison forecasts a full year FY27 dividend of 0.00 cents and EPS of 5.80 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 7.59.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
EDV ENDEAVOUR GROUP LIMITED
Food, Beverages & Tobacco – Overnight Price: $3.89
Jarden rates ((EDV)) as Underweight (4) –
Jarden found the pre-announced first half result from Endeavour Group contained few surprises. The focus was on the second half and the new strategy, which will be outlined on May 27.
So far the company’s strategy is to retain both retail and hotel businesses in the portfolio.
Going forward, the broker envisages some risk that further price investment will be required, but there remain plenty of opportunities for the business to capitalise on brand strength, loyalty and cross selling.
Caution prevails and an Underweight rating is retained until there is further clarity around the reset under the new CEO. Target price is reduced to $3.10 from $3.20.
This report was published on March 4, 2026.
Target price is $3.10 Current Price is $3.89 Difference: minus $0.79 (current price is over target).
If EDV meets the Jarden target it will return approximately minus 20% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $3.79, suggesting downside of -2.4%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 14.80 cents and EPS of 21.40 cents.
At the last closing share price the estimated dividend yield is 3.80%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 18.18.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 21.8, implying annual growth of -8.4%.
Current consensus DPS estimate is 15.9, implying a prospective dividend yield of 4.1%.
Current consensus EPS estimate suggests the PER is 17.8.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 17.00 cents and EPS of 23.60 cents.
At the last closing share price the estimated dividend yield is 4.37%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 16.48.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 23.5, implying annual growth of 7.8%.
Current consensus DPS estimate is 16.4, implying a prospective dividend yield of 4.2%.
Current consensus EPS estimate suggests the PER is 16.5.
Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
ELD ELDERS LIMITED
Agriculture – Overnight Price: $7.04
Canaccord Genuity rates ((ELD)) as Buy (1) –
Elders has an agreement with Australian Meat Group to sell its Killara feedlot for $196m, removing a low return on capital asset.
Canaccord Genuity considers the transaction in a positive light, notably because of the reduction in debt and the broadly neutral impact on earnings.
Trading conditions appear to have improved in recent weeks amid favourable weather in Western and South Australia, likely to drive an uplift in crop input demand, commentary suggests.
Buy rating retained and the target is raised to $8.64 from $8.08.
This report was published on March 2, 2026.
Target price is $8.64 Current Price is $7.04 Difference: $1.6
If ELD meets the Canaccord Genuity target it will return approximately 23% (excluding dividends, fees and charges).
Current consensus price target is $8.68, suggesting upside of 21.8%(ex-dividends)
The company’s fiscal year ends in September.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 36.00 cents and EPS of 53.00 cents.
At the last closing share price the estimated dividend yield is 5.11%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 13.28.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 57.1, implying annual growth of 109.8%.
Current consensus DPS estimate is 37.0, implying a prospective dividend yield of 5.2%.
Current consensus EPS estimate suggests the PER is 12.5.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 36.00 cents and EPS of 54.00 cents.
At the last closing share price the estimated dividend yield is 5.11%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 13.04.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 63.4, implying annual growth of 11.0%.
Current consensus DPS estimate is 40.3, implying a prospective dividend yield of 5.7%.
Current consensus EPS estimate suggests the PER is 11.2.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
FLC FLUENCE CORPORATION LIMITED
Industrial Sector Contractors & Engineers – Overnight Price: $0.08
Research as a Service (RaaS) rates ((FLC)) as No Rating (-1) –
Fluence delivered a 2025 full year result in line with previous updates. Research as a Service (RaaS) notes successful delivery of the IVC Addendum project was the most material financial driver of revenue and adjusted EBITDA that were ahead of forecasts.
This was complemented by ongoing success in the strategically important SPS revenue segment, which grew 15.2%. The broker believes the business is well-positioned for further growth although no numerical guidance was provided.
The backlog of the contracted order book sits at US$75m, US$54m of which is expected to be recognised in FY26. Valluation is steady at $0.18.
Research as a Service (RaaS) research doesn’t carry any targets, ratings or recommendations. Investors can draw conclusions from valuations and commentary.
This report was published on March 3, 2026.
Target price is $0.18 Current Price is $0.08 Difference: $0.101
If FLC meets the Research as a Service (RaaS) target it will return approximately 128% (excluding dividends, fees and charges).
The company’s fiscal year ends in December.
Forecast for FY26:
Research as a Service (RaaS) forecasts a full year FY26 EPS of 51.72 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 0.15.
Forecast for FY27:
Research as a Service (RaaS) forecasts a full year FY27 EPS of 106.48 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 0.07.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
GHM GOLDEN HORSE MINERALS LIMITED
Overnight Price: $0.66
Shaw and Partners rates ((GHM)) as Buy (1) –
Golden Horse Minerals has confirmed high-grade gold mineralisation at depth and extended the Hopes Hill strike by 700m, Shaw and Partners notes, supporting resource growth potential.
The broker highlights drilling including 7.1m at 2.5g/t gold and 4.0m at 3.1g/t gold below the historic pit, indicating the system remains open down plunge.
A 125,000m drilling campaign and a 1,800sqkm landholding support regional exploration, including new work at the Marionete prospect, observe the analysts.
It’s thought strong gold prices and exploration momentum support a maiden resource estimate and broader development potential.
Buy, High-Risk rating and $1.50 target are maintained.
This report was published on March 6, 2026.
Target price is $1.50 Current Price is $0.66 Difference: $0.84
If GHM meets the Shaw and Partners target it will return approximately 127% (excluding dividends, fees and charges).
The company’s fiscal year ends in December.
Forecast for FY25:
Shaw and Partners forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 3.50 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 18.86.
Forecast for FY26:
Shaw and Partners forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 2.10 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 31.43.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
GNP GENUSPLUS GROUP LIMITED
Infrastructure & Utilities – Overnight Price: $7.90
Moelis rates ((GNP)) as Buy (1) –
GenusPlus Group will acquire rail infrastructure services provider Rail train Holdings for -$36.5m and up to -$18m in contingent earnout payments.
Moelis calculates the consideration in total implies a multiple of 2.75x EBITDA, assuming maximum earnout targets are achieved.
The broker upgrades FY26-28 estimates for EPS by 2-10%, highlighting continued conversion of pipeline in transmission, energy transition and communication sector growth represent upside risk to the outer years.
The business appears well supported and Moelis retains a Buy rating. Target rises to $9.49 from $8.88.
This report was published on March 5, 2026.
Target price is $9.49 Current Price is $7.90 Difference: $1.59
If GNP meets the Moelis target it will return approximately 20% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Moelis forecasts a full year FY26 dividend of 6.50 cents and EPS of 27.10 cents.
At the last closing share price the estimated dividend yield is 0.82%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 29.15.
Forecast for FY27:
Moelis forecasts a full year FY27 dividend of 7.30 cents and EPS of 30.40 cents.
At the last closing share price the estimated dividend yield is 0.92%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 25.99.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
MSB MESOBLAST LIMITED
Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $2.18
Canaccord Genuity rates ((MSB)) as Buy (1) –
Canaccord Genuity assesses expenses will increase for Mesoblast across the forecast period, noting first half results and FY26 revenue guidance were in line with expectations.
There may be opportunities to beat forecasts yet the broker recognises Ryoncil, in the market for less than a full year, is yet to reflect adherence and seasonality pattterns.
Canaccord Genuity currently models incremental revenue from FY28 for Revascor in heart failure but has lingering questions regarding whether the US FDA will consider post-hoc reinterpretation for full approval adequate.
Buy rating retained. Target is reduced to $3.23 from $3.32.
This report was published on March 2, 2026.
Target price is $3.23 Current Price is $2.18 Difference: $1.05
If MSB meets the Canaccord Genuity target it will return approximately 48% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
MYE MASTERMYNE GROUP LIMITED
Mining Sector Contracting – Overnight Price: $0.20
Research as a Service (RaaS) rates ((MYE)) as No Rating (-1) –
Mastermyne Group, an Australian underground coal mining contractor, had a challenging FY25 yet having resolved most of the issues and commenced new contracts a recovery was confirmed in the first half results, where EBITDA exceeded Research as a Service’s (RaaS) expectations.
Margins improved and the order book expanded to $441m, up 79% year-on-year. The broker considers the stock materially undervalued, trading at “compelling” multiples on its FY26 forecasts.
The main concern is a resolution of the outstanding litigation with the regulator, set for trial this month. Valuation is $0.35.
Research as a Service (RaaS) research doesn’t carry any targets, ratings or recommendations. Investors can draw conclusions from valuations and commentary.
This report was published on March 3, 2026.
Target price is $0.35 Current Price is $0.20 Difference: $0.15
If MYE meets the Research as a Service (RaaS) target it will return approximately 75% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Research as a Service (RaaS) forecasts a full year FY26 EPS of 2.80 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 7.14.
Forecast for FY27:
Research as a Service (RaaS) forecasts a full year FY27 EPS of 3.60 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 5.56.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
ORA ORORA LIMITED
Paper & Packaging – Overnight Price: $1.94
Jarden rates ((ORA)) as Buy (1) –
Orora has gone “some way” to easing market concerns that have dominated investor sentiment, Jarden observes. Saverglass has returned to volume growth and FY26 guidance has been maintained.
The broker envisages core EPS downgrades for FY26-27 will now be driven by FX adjustments. The stock has underperformed the market since the results with concerns about the Saverglass customer outlook dominating discussions.
Jarden envisages some time before the market gets more clarity on the issues yet sets this concern aside, comforted by the strong balance sheet. Buy rating and $2.60 target maintained.
This report was published on March 3, 2026.
Target price is $2.60 Current Price is $1.94 Difference: $0.66
If ORA meets the Jarden target it will return approximately 34% (excluding dividends, fees and charges).
Current consensus price target is $2.29, suggesting upside of 18.0%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 10.10 cents and EPS of 13.40 cents.
At the last closing share price the estimated dividend yield is 5.21%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 14.48.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 13.2, implying annual growth of 22.7%.
Current consensus DPS estimate is 10.3, implying a prospective dividend yield of 5.3%.
Current consensus EPS estimate suggests the PER is 14.7.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 12.50 cents and EPS of 16.70 cents.
At the last closing share price the estimated dividend yield is 6.44%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 11.62.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 14.9, implying annual growth of 12.9%.
Current consensus DPS estimate is 11.0, implying a prospective dividend yield of 5.7%.
Current consensus EPS estimate suggests the PER is 13.0.
Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
ORE OREZONE GOLD CORPORATION REGISTERED
Gold & Silver – Overnight Price: $2.35
Canaccord Genuity rates ((ORE)) as Buy (1) –
Orezone Gold delivered fourth quarter gold production of 30,400 ounces, missing Canaccord Genuity’s estimates and driving a miss to EBITDA and earnings per share. Full year 2025 production of 110,000 ounces was below guidance.
While the quarterly results were below expectations, the broker is focused on the Bombore staged hard rock expansion, which should double production, along with the pending acquisition of the Casa Berardi mine in Quebec.
Buy rating and $4 target unchanged.
This report was published on March 2, 2026.
Target price is $4.00 Current Price is $2.35 Difference: $1.65
If ORE meets the Canaccord Genuity target it will return approximately 70% (excluding dividends, fees and charges).
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
PDN PALADIN ENERGY LIMITED
Uranium – Overnight Price: $11.95
Shaw and Partners rates ((PDN)) as Buy (1) –
Shaw and Partners assesses the uranium market is in the early stages of a “super cycle” and expects prices will increase to around US$200/lb before reverting to a long-term sustainable price of US$120/lb next decade.
Paladin Energy will shift the focus to Patterson Lake South after completing a successful ramp up of Langer Heinrich to full capacity in mid 2026.
The broker notes the share price has re-rated as the market recognises the commissioning issues at the latter were temporary. The next phase of outperformance is exppected to be driven by the strengthening uranium market.
Buy, High Risk rating retained. Target is $17.50.
This report was published on March 5, 2026.
Target price is $17.50 Current Price is $11.95 Difference: $5.55
If PDN meets the Shaw and Partners target it will return approximately 46% (excluding dividends, fees and charges).
Current consensus price target is $12.46, suggesting upside of 2.1%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Shaw and Partners forecasts a full year FY26 dividend of 0.00 cents and EPS of 25.86 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 46.21.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 7.7, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 158.4.
Forecast for FY27:
Shaw and Partners forecasts a full year FY27 dividend of 15.70 cents and EPS of 126.71 cents.
At the last closing share price the estimated dividend yield is 1.31%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 9.43.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 37.1, implying annual growth of 381.8%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 32.9.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
SLS SOLSTICE MINERALS LIMITED
Overnight Price: $0.92
Canaccord Genuity rates ((SLS)) as Initiate coverage with Speculative Buy (1) –
Solstice Minerals is exploring the Nanadie copper-gold project in Western Australia’s Murchison district. It also holds the Yarri gold project near Kalgoorlie.
A phase1 RC campaign was recently executed at Nanadie to test resource extensions and returned wide higher-grade intercepts from the outside of the existing resource including 62m at 1.55% copper and 0.66g/t gold from 256m to the end of hole and 97m at 0.73% copper and 0.30g/t gold from 203m to the end of hole.
Canaccord Genuity highlights this is not your average copper deposit, hosted in a mafic-ultramafic intrusion but appearing devoid of nickel and PGM. The broker initiates coverage of the stock with a Speculative Buy rating and a $1.85 target.
This report was published on March 3, 2026.
Target price is $1.85 Current Price is $0.92 Difference: $0.935
If SLS meets the Canaccord Genuity target it will return approximately 102% (excluding dividends, fees and charges).
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
SNZ SUMMERSET GROUP HOLDINGS LIMITED
Overnight Price: $8.50
Jarden rates ((SNZ)) as Neutral (3) –
Summerset Group’s FY25 result highlighted free cash generation from mature retirement villages, Jarden notes, with returns partly supported by refinancing margins on resales.
It’s noted free cash returns across 16 mature villages remain volatile year-to-year and should be assessed over longer periods.
The analysts observe operating earnings from mature villages are under pressure from rising operating deficits and longer resident tenures reducing deferred management fee timing.
Lower unit price growth could reduce refinancing margins, cautions the broker, increasing reliance on operating earnings to sustain free cash returns.
Neutral rating and target of NZ$11.44 are maintained.
This report was published on March 2, 2026.
Current Price is $8.50. Target price not assessed.
The company’s fiscal year ends in December.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 4.29 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 198.18.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 0.00 cents and EPS of minus 2.77 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 306.86.
This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
TCL TRANSURBAN GROUP LIMITED
Infrastructure & Utilities – Overnight Price: $14.11
Jarden rates ((TCL)) as Neutral (3) –
Jarden highlights Transurban Group offers defensive toll road assets with long concession lives and inflation-linked revenue, supporting stable cash flows and income.
Further, the broker notes growth optionality exists through upgrades in Brisbane, North America projects and potential new markets including Atlanta, Nashville and New Zealand.
Refinancing risk is highlighted, with $5.4bn, $5.1bn and $3.6bn of debt maturing across FY27-FY29 likely lifting future interest costs.
Traffic growth risks are thought to include West Gate Tunnel performance, autonomous vehicle adoption and technological efficiencies reducing transport demand.
Jarden reduces its target price to $13.50 from $13.60 and retains a Neutral rating.
This report was published on March 2, 2026.
Target price is $13.50 Current Price is $14.11 Difference: minus $0.61 (current price is over target).
If TCL meets the Jarden target it will return approximately minus 4% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $14.44, suggesting upside of 1.4%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 69.00 cents and EPS of 17.60 cents.
At the last closing share price the estimated dividend yield is 4.89%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 80.17.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 33.0, implying annual growth of 671.0%.
Current consensus DPS estimate is 69.1, implying a prospective dividend yield of 4.9%.
Current consensus EPS estimate suggests the PER is 43.1.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 72.00 cents and EPS of 22.60 cents.
At the last closing share price the estimated dividend yield is 5.10%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 62.43.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 33.3, implying annual growth of 0.9%.
Current consensus DPS estimate is 72.8, implying a prospective dividend yield of 5.1%.
Current consensus EPS estimate suggests the PER is 42.7.
Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
TLC LOTTERY CORPORATION LIMITED
Gaming – Overnight Price: $5.32
Jarden rates ((TLC)) as Overweight (2) –
Lottery Corp has made changes to its operating model designed to accelerate growth, which Jarden finds significant.
The changes reflect a reset of the business rather than just cosmetic restructuring, commentary concludes, with distinct business units that have explicit growth mandates and clear P&L accountability.
A stand-alone digital business with the remit to drive digital lottery sales and deliver “world-class app and web experiences” could accelerate structural digital penetration, the broker points out, while lottteries has upside risk and is a primary growth lever for the business.
No additional information on personnel or cost imposts was announced. Overweight rating and $5.60 target maintained.
This report was published on March 5, 2026.
Target price is $5.60 Current Price is $5.32 Difference: $0.28
If TLC meets the Jarden target it will return approximately 5% (excluding dividends, fees and charges).
Current consensus price target is $5.78, suggesting upside of 8.3%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 16.50 cents and EPS of 17.00 cents.
At the last closing share price the estimated dividend yield is 3.10%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 31.29.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 17.2, implying annual growth of 4.7%.
Current consensus DPS estimate is 17.4, implying a prospective dividend yield of 3.3%.
Current consensus EPS estimate suggests the PER is 31.0.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 18.00 cents and EPS of 20.20 cents.
At the last closing share price the estimated dividend yield is 3.38%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 26.34.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 20.1, implying annual growth of 16.9%.
Current consensus DPS estimate is 20.3, implying a prospective dividend yield of 3.8%.
Current consensus EPS estimate suggests the PER is 26.5.
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
WEB WEB TRAVEL GROUP LIMITED
Travel, Leisure & Tourism – Overnight Price: $2.85
Canaccord Genuity rates ((WEB)) as Buy (1) –
The CFO of Web Travel, Tony Ristevski, has withdrawn his resignation and will remain with the company.
Canaccord Genuity notes the departure had created angst among some shareholders, with the uncertainty surrounding prospective issues within the accounts or outlook.
The broker did not hold this view, suspecting the resignation was related to personal matters and, while not sure about the exact process to reverse the decision, considers it a positive outcome.
Notwithstanding this development, the share price is materially weaker given the commencement of military action in the Middle East and subsequent booking patterns.
Minimal impact is expected in FY26 and there may be some impact in FY27 depending on how long the war continues.
Canaccord Genuity considers, even with the disruption in the Middle East, the worst-case scenario is Web Travel grows more slowly at a group level as that region acts as a drag against continued strong transaction growth in other areas.
Buy rating and $6.40 target unchanged.
This report was published on March 2, 2026.
Target price is $6.40 Current Price is $2.85 Difference: $3.55
If WEB meets the Canaccord Genuity target it will return approximately 125% (excluding dividends, fees and charges).
Current consensus price target is $5.73, suggesting upside of 105.3%(ex-dividends)
Forecast for FY26:
Current consensus EPS estimate is 23.8, implying annual growth of -54.4%.
Current consensus DPS estimate is 1.7, implying a prospective dividend yield of 0.6%.
Current consensus EPS estimate suggests the PER is 11.7.
Forecast for FY27:
Current consensus EPS estimate is 32.1, implying annual growth of 34.9%.
Current consensus DPS estimate is 2.5, implying a prospective dividend yield of 0.9%.
Current consensus EPS estimate suggests the PER is 8.7.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
WRK WRKR LIMITED
Overnight Price: $0.12
Research as a Service (RaaS) rates ((WRK)) as No Rating (-1) –
Wrkr, which offers compliance solutions for Australian superannuation contributions and payroll, has completed the acquisition of PaidRight, a payroll compliance software company.
Research as a Service (RaaS) notes the acquisition is strategic, and the company is likely to benefit from up-selling opportunities from MUFG clients migrating to WRK Pay.
The first half result provided revenue and EBITDA that was above forecasts, while costs increased in readiness for new client onboarding during the second half.
Incorporating the acquisition into its numbers, the analyst reduces earnings assumptions by -8% for FY27 and increases FY29 by 15%. Valuation increases to $0.125 from $0.110.
Research as a Service (RaaS) research doesn’t carry any targets, ratings or recommendations. Investors can draw conclusions from valuations and commentary.
This report was published on March 5, 2026.
Target price is $0.13 Current Price is $0.12 Difference: $0
If WRK meets the Research as a Service (RaaS) target it will return approximately 0% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Research as a Service (RaaS) forecasts a full year FY26 dividend of 0.00 cents and EPS of 0.17 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 73.53.
Forecast for FY27:
Research as a Service (RaaS) forecasts a full year FY27 dividend of 0.00 cents and EPS of 0.56 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 22.32.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
Disclaimer:
The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don’t have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide experienced, intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface.
This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.
<span style="
Click to view our Glossary of Financial Terms
CHARTS
For more info SHARE ANALYSIS: AEL - AMPLITUDE ENERGY LIMITED
For more info SHARE ANALYSIS: BET - BETMAKERS TECHNOLOGY GROUP LIMITED
For more info SHARE ANALYSIS: BMN - BANNERMAN ENERGY LIMITED
For more info SHARE ANALYSIS: CNB - CARNABY RESOURCES LIMITED
For more info SHARE ANALYSIS: CSL - CSL LIMITED
For more info SHARE ANALYSIS: CSX - CLEANSPACE HOLDINGS LIMITED
For more info SHARE ANALYSIS: CYG - COVENTRY GROUP LIMITED
For more info SHARE ANALYSIS: EDV - ENDEAVOUR GROUP LIMITED
For more info SHARE ANALYSIS: ELD - ELDERS LIMITED
For more info SHARE ANALYSIS: FLC - FLUENCE CORPORATION LIMITED
For more info SHARE ANALYSIS: GHM - GOLDEN HORSE MINERALS LIMITED
For more info SHARE ANALYSIS: GNP - GENUSPLUS GROUP LIMITED
For more info SHARE ANALYSIS: MSB - MESOBLAST LIMITED
For more info SHARE ANALYSIS: MYE - MASTERMYNE GROUP LIMITED
For more info SHARE ANALYSIS: ORA - ORORA LIMITED
For more info SHARE ANALYSIS: ORE - OREZONE GOLD CORPORATION CDI
For more info SHARE ANALYSIS: PDN - PALADIN ENERGY LIMITED
For more info SHARE ANALYSIS: SLS - SOLSTICE MINERALS LIMITED
For more info SHARE ANALYSIS: SNZ - SUMMERSET GROUP HOLDINGS LIMITED
For more info SHARE ANALYSIS: TCL - TRANSURBAN GROUP LIMITED
For more info SHARE ANALYSIS: TLC - LOTTERY CORPORATION LIMITED
For more info SHARE ANALYSIS: WEB - WEB TRAVEL GROUP LIMITED
For more info SHARE ANALYSIS: WRK - WRKR LIMITED